EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Thermostable vacuum foam dried Newcastle disease vaccine: Process optimization and pilot-scale study

Fang Lyu, Yan-Hong Zhao, Xiao-Xin Zuo, Babalwa Nyide, Bi-Hua Deng, Ming-Xu Zhou, Jibo Hou, Jia-Jie Jiao, Min-Qian Zeng, Hong-Ying Jie, Ademola Olaniran, Yu Lu und 1 weitere

Applied Microbiology and Biotechnology · 2024-12 · 108 (1)

DOI: 10.1007/s00253-024-13174-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, online erschienen am 05.06.2024. Verfasst von Fang Lyu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Veterinary Immunology & Engineering, National Research Center of Engineering and Technology for Veterinary Biologicals, Jiangsu Academy …. Hauptthemen laut MEDLINE: Newcastle disease virus, Newcastle Disease, Viral Vaccines, Temperature. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Agricultural Science and Technology Independent Innovation Fund, The Key Research and Development Program of Jiangsu Province, NRF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vacuum foam drying (VFD) has been shown to improve the thermostability and long-term shelf life of Newcastle Disease Virus (NDV). This study optimized the VFD process to improve the shelf life of NDV at laboratory-scale and then tested the optimized conditions at pilot-scale. The optimal NDV to T5 formulation ratio was determined to be 1:1 or 3:2. Using the 1:1 virus to formulation ratio, the optimal filling volumes were determined to be 13–17% of the vial capacity. The optimized VFD process conditions were determined to be at a shelf temperature of 25℃ with a minimum overall drying time of 44 h. The vaccine samples prepared using these optimized conditions at laboratory-scale exhibited virus titer losses of ≤ 1.0 log 10 with residual moisture content (RMC) below 3%. Furthermore, these samples were transported for 97 days around China at ambient temperature without significant titer loss, thus demonstrating the thermostability of the NDV-VFD vaccine. Pilot-scale testing of the NDV-VFD vaccine at optimized conditions showed promising results for up-scaling the process as the RMC was below 3%. However, the virus titer loss was slightly above 1.0 log 10 (approximately 1.1 log 10 ). Therefore, the NDV-VFD process requires further optimization at pilot scale to obtain a titer loss of ≤ 1.0 log 10 . Results from this study provide important guidance for possible industrialization of NDV-VFD vaccine in the future. Key points • The process optimization and scale-up test of thermostable NDV vaccine prepared through VFD is reported for the first time in this study. • The live attenuated NDV-VFD vaccine maintained thermostability for 97 days during long distance transportation in summer without cold chain conditions. • The optimized NDV-VFD vaccine preparations evaluated at pilot-scale maintained acceptable levels of infectivity after preservation at 37℃ for 90 days, which demonstrated the feasibility of the vaccine for industrialization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Newcastle disease virusNewcastle DiseaseViral VaccinesTemperaturePilot ProjectsVacuumAnimalsChickensDesiccationChinaDrug StabilityViral Load

Stichwörter der Autor:innen

NDV vaccineProcess upscalingThermostabilityVacuum foam drying

Substanzen

Viral Vaccines

Autor:innen und Institutionen

  • Institute of Veterinary Immunology & Engineering, National Research Center of Engineering and Technology for Veterinary Biologicals, Jiangsu Academy of Agricultural Sciences, Nanjing, 210014, China.
  • Department of Biochemistry, School of Life Sciences, College of Agriculture, Engineering & Science, University of KwaZulu-Natal, Pietermaritzburg, 3209, South Africa.
  • GuoTai (Taizhou) Center of Technology Innovation for Veterinary Biologicals, Taizhou, 225300, China.
  • School of Animal Medicine, Nanjing Agricultural University, Nanjing, 210095, Jiangsu, China.
  • Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology, Nanjing, 210014, China.
  • Department of Microbiology, School of Life Sciences, Engineering & Science, College of Agriculture, University of KwaZulu-Natal, Durban, 4000, South Africa.

Förderung

  • Jiangsu Agricultural Science and Technology Independent Innovation Fund
  • The Key Research and Development Program of Jiangsu Province
  • NRF
  • University of KwaZulu Natal Research grant
  • MRC SIR Grant
  • University of KwaZulu-Natal

Zitieren

APA

Lyu, F., Zhao, Y. H., Zuo, X. X., Nyide, B., Deng, B. H., Zhou, M. X., Hou, J., Jiao, J. J., Zeng, M. Q., Jie, H. Y., Olaniran, A., Lu, Y., & Khoza, T. (2024). Thermostable vacuum foam dried Newcastle disease vaccine: Process optimization and pilot-scale study. Applied Microbiology and Biotechnology, 108(1). https://doi.org/10.1007/s00253-024-13174-7

Vancouver

Lyu F, Zhao YH, Zuo XX, Nyide B, Deng BH, Zhou MX, et al. Thermostable vacuum foam dried Newcastle disease vaccine: Process optimization and pilot-scale study. Applied Microbiology and Biotechnology. 2024;108(1). doi:10.1007/s00253-024-13174-7

BibTeX
@article{Lyu2024,
  author = {Lyu, Fang and Zhao, Yan-Hong and Zuo, Xiao-Xin and Nyide, Babalwa and Deng, Bi-Hua and Zhou, Ming-Xu and Hou, Jibo and Jiao, Jia-Jie and Zeng, Min-Qian and Jie, Hong-Ying and Olaniran, Ademola and Lu, Yu and Khoza, Thandeka},
  title = {Thermostable vacuum foam dried Newcastle disease vaccine: Process optimization and pilot-scale study},
  journal = {Applied Microbiology and Biotechnology},
  year = {2024},
  volume = {108},
  number = {1},
  doi = {10.1007/s00253-024-13174-7}
}
Kostenlos starten →